CT测量的心脏指标与COVID-19患者肺部受累及临床结局的关联
研究纳入87例确诊COVID-19并接受胸部CT的患者,测量肺动脉与主动脉比值、心胸比、心外膜脂肪厚度与密度、下腔静脉直径及气管横径与前后径比值等心脏指标。结果显示心胸比>0.49见于52.9%的患者,与死亡风险增高相关(OR=12.5,p=0.005;HR=11.4,p=0.006);肺动脉与主动脉比值>1见于20.7%的患者,与死亡风险无显著关联(OR=1.9,p=0.36);广泛肺部受累与心胸比升高及肺动脉与主动脉比值增大正相关(p=0.001)。结论认为CT测量的心脏指标可能对住院COVID-19患者的生存和肺部受累程度有预测价值,其中心胸比增高是死亡的强预测因子。
要点
- 心胸比>0.49见于52.9%的COVID-19患者,与死亡风险增高独立相关(OR=12.5,p=0.005;HR=11.4,p=0.006)。
- 肺动脉与主动脉比值>1见于20.7%的患者,与死亡风险无显著关联(OR=1.9,p=0.36)。
- 广泛肺部受累(基于CT评分)与心胸比升高及肺动脉与主动脉比值增大正相关(p=0.001)。
核心结论
- CT测量的心脏指标可能对住院COVID-19患者的生存和肺部受累程度有预测价值,并可能用于风险分层和治疗决策。
- 其中心胸比增高在COVID-19患者中常见,是死亡的强预测因子。
研究设计与样本
- 研究类型为观察性研究,纳入87例确诊COVID-19并接受胸部CT的患者。
- 采用非增强CT测量心脏指标,包括肺动脉与主动脉比值、心胸比、心外膜脂肪厚度与密度、下腔静脉直径及气管横径与前后径比值。
- 采用Logistic回归和Cox回归分析心脏指标与结局(死亡 vs 出院)的关联,采用线性回归分析肺部受累程度(基于CT评分)与心脏指标的关系。
诊断标准与关键数值
- 心胸比>0.49见于52.9%的患者,与死亡风险增高相关(OR=12.5,p=0.005;HR=11.4,p=0.006)。
- 肺动脉与主动脉比值>1见于20.7%的患者,与死亡风险无显著关联(OR=1.9,p=0.36)。
- 广泛肺部受累与心胸比升高及肺动脉与主动脉比值增大正相关(p=0.001)。
临床应用与阅片要点
- 作者认为CT测量的心脏指标可能用于住院COVID-19患者的风险分层和治疗决策。
- 作者指出心胸比增高是死亡的强预测因子。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Cardiac indices can predict disease severity and survival in a multitude of respiratory and cardiovascular diseases. Herein, we hypothesized that CT-measured cardiac indices are correlated with severity of lung involvement and can predict survival in patients with COVID-19.
MATERIALS AND METHODS: Eighty-seven patients with confirmed COVID-19 who underwent chest CT were enrolled. Cardiac indices including pulmonary artery-to-aorta ratio (PA/A), cardiothoracic ratio (CTR), epicardial adipose tissue (EAT) thickness and EAT density, inferior vena cava diameter, and transverse-to-anteroposterior trachea ratio were measured by non-enhanced CT. Logistic regression and Cox-regression analyses evaluated the association of cardiac indices with patients' outcome (death vs discharge). Linear regression analysis was used to assess the relationship between the extent of lung involvement (based on CT score) and cardiac indices.
RESULTS: Mean (±SD) age of patients was 54.55 (±15.3) years old; 65.5% were male. Increased CTR (>0.49) was seen in 52.9% of patients and was significantly associated with increased odds and hazard of death (odds ratio [OR] = 12.5, p = 0.005; hazard ratio = 11.4, p = 0.006). PA/A >1 was present in 20.7% of patients and displayed a nonsignificant increase in odds of death (OR = 1.9, p = 0.36). Furthermore, extensive lung involvement was positively associated with elevated CTR and increased PA/A (p = 0.001).
CONCLUSION: CT-measured cardiac indices might have predictive value regarding survival and extent of lung involvement in hospitalized patients with COVID-19 and could possibly be used for the risk stratification of these patients and for guiding therapy decision-making. In particular, increased CTR is prevalent in patients with COVID-19 and is a powerful predictor of mortality.
引用
- Eslami V, Abrishami A, Zarei E, et al. The Association of CT-measured Cardiac Indices with Lung Involvement and Clinical Outcome in Patients with COVID-19. Acad Radiol. 2020. PMID: 33041195. doi:10.1016/j.acra.2020.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。